Corrigendum: A Personalized Approach to Treatment: Use of EGFR Tyrosine Kinase Inhibitors for the Treatment of Non-Small-Cell Lung Cancer in Canada
Current Oncology - Canada
doi 10.3747/co.19.1150
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 5, 2012
Authors
Publisher
MultiMed Inc.